INS and Hypoglycemia: Consistent with the kinetics of the insulin-antibody complex in IAS, we could infer that our patient presented with hyperglycemia at the beginning of the postprandial period, explained by the antibodies that bound to the endogenous insulin, with subsequent late occurrence of hypoglycemia when the antibodies dissociated from the insulin, increasing availability.